HealthTree Podcast for Multiple Myeloma (formerly known as Myeloma Crowd Radio) is an hour-long podcast series of patient-led interviews with top multiple myeloma experts. This was the very first program created by the HealthTree Foundation for Multiple Myeloma (Myeloma Crowd).
A majority of the interviews focus on learning about an open multiple myeloma clinical trial: who is eligible, what is the treatment, and how the trial can benefit you.
During each show, we are focused on simplifying the conversation and asking patient questions about the topic so the doctor can explain the subject in patient-friendly-language.
At the end of the interview, the show is opened up to listener questions and anyone is welcome to dial-in and ask questions about what was discussed.
Over 2 million people have listened to over 155 HealthTree Podcast for Multiple Myeloma Episodes.
August 02, 2022
Paul Richardson, MD of the Dana Farber Cancer Institute joins the HealthTree Podcast for multiple myeloma for a mid-year update
July 07, 2022
Learn more about allogeneic ("off-the-shelf") CAR T therapies in development with CAR T expert Jesus Berdeja, MD
March 09, 2022
What can myeloma patients expect to see in 2022 for multiple myeloma therapy? Join this overall review of the myeloma landscape on Myeloma Crowd Radio with Dr. Robert Orlowski, MD, PhD, of MD Anderson Cancer Center.
January 25, 2022
A new treatment called Engineered Toxin Bodies is in development in multiple myeloma. Learn more with Dr. Shaji Kumar.
January 19, 2022
A new treatment is in early myeloma clinical trials testing tasquinimod to treat roque immune cells called MDSCs. Learn more in this informative show with Drs. Dan Vogl and Yulia Nefedova.
November 21, 2021
A smoldering myeloma update with Elisabet Manasanch, MD of MD Anderson Cancer Center
October 25, 2021
BLENREP is a new myeloma drug targeting BCMA. Learn how to manage the side effect called keratopathy while using it.
June 09, 2021
Learn how monoclonal antibodies are being used for newly diagnosed myeloma in this interesting show with Peter Voorhees, MD of the Levine Cancer Institute.
June 01, 2021
AL Amyloidosis is a condition that can occur with multiple myeloma. Learn from amyloidosis and myeloma expert Dr. Sascha Tuchman on Myeloma Crowd Radio about signs, symptoms and the latest treatment.
April 27, 2021
Now that Abecma (CAR T therapy) is approved in multiple myeloma, learn more about who is eligible and when you may want to consider using it after four prior lines of therapy.